What side effects are associated with this type of intervention?

Common treatments for colon cancer include surgery, chemotherapy, radiation therapy, and targeted therapy. Surgery can lead to side effects such as pain, infection, and changes in bowel function. Chemotherapy often causes nausea, vomiting, fatigue, hair loss, and increased risk of infection. Radiation therapy may result in skin irritation, fatigue, and gastrointestinal issues like diarrhea. Targeted therapy can cause side effects such as high blood pressure, fatigue, and skin problems. Educational support via digital information dissemination can help patients manage these side effects by providing timely information and coping strategies.

What prior FDA approvals exist?

FDA-approved treatments for colon cancer include a variety of chemotherapeutic agents and targeted therapies. Commonly used drugs include fluorouracil (5-FU), oxaliplatin, and irinotecan, often used in combination regimens like FOLFOX (5-FU, leucovorin, and oxaliplatin) and FOLFIRI (5-FU, leucovorin, and irinotecan). Targeted therapies such as bevacizumab, cetuximab, and panitumumab are also approved for specific cases, particularly those involving metastatic disease. These treatments, along with supportive care measures, are likely topics covered in the educational support study using computer tablets to help patients and caregivers manage colon cancer care effectively.

What other types of research exist?

Promising alternatives to educational support via computer tablets for colon cancer patients include: 1) Automated text messaging programs, which have been shown to improve adherence to medical procedures. 2) Mobile health apps, which can provide personalized support and real-time monitoring. 3) Web-based interventions, which can offer comprehensive educational resources and support. 4) Face-to-face interactions, which may be preferred by some patients for personalized guidance and support.

← Back to Search

Quality of Life Interventions for Colon Cancer

N/A

Recruiting

Led By Kevin D Cassel, Dr. PH

Research Sponsored by University of Hawaii

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline to 3 months

Awards & highlights

Summary

This trial provides colon cancer patients and their caregivers with tablets containing helpful information about the disease and its treatment. Regular support and surveys aim to reduce anxiety, improve communication with doctors, and enhance overall care.

Who is the study for?

This trial is for adult colon cancer patients and their caregivers in Honolulu County. Patients must be newly diagnosed with stage II-III colon cancer, within 60 days post-surgery, and able to understand and write English. Caregivers can be family or someone the patient identifies as a caregiver.

What is being tested?

The study provides educational resources about colon cancer via tablets to improve quality of life for patients and caregivers. It includes weekly check-ins from the study team, use of information provided on tablets, and completing surveys assessing its impact.

What are the potential side effects?

There are no medical side effects since this isn't a drug trial; however, there may be a slight burden due to time spent responding to survey questions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline to 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline to 3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Perception of Care Coordination Caregiver

Perception of Care Coordination Participant

Quality of Life Scores

Trial Design

2Treatment groups

Experimental Treatment

Group I: Group AExperimental Treatment1 Intervention

Ted Talks/Educational videos

Group II: Group 1Experimental Treatment1 Intervention

Supportive Care Materials and Resources

Do I qualify?Apply below to find out

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.

Mechanism Of Action

Side Effect Profile

Prior Approvals

Other Research

Common treatments for colon cancer include surgery, chemotherapy, targeted therapy, and immunotherapy. Surgery removes the tumor, which is essential for localized cancer. Chemotherapy kills rapidly dividing cancer cells, reducing tumor size and preventing spread. Targeted therapy focuses on specific molecular targets, minimizing damage to normal cells. Immunotherapy enhances the immune system's ability to recognize and destroy cancer cells. Understanding these mechanisms helps patients grasp how treatments work, the rationale behind their treatment plan, and potential side effects, improving their engagement and adherence to therapy.

Personalized nutrition intervention improves nutritional status and quality of life of colorectal cancer survivors in the community: A randomized controlled trial.Comparative effectiveness of chemopreventive interventions for colorectal cancer: protocol for a systematic review and network meta-analysis of randomised controlled trials.Colorectal cancer: prevention and management of metastatic disease.

Find a Location

Who is running the clinical trial?

University of HawaiiLead Sponsor

119 Previous Clinical Trials

56,842 Total Patients Enrolled

Alliance for Clinical Trials in OncologyOTHER

512 Previous Clinical Trials

217,352 Total Patients Enrolled

Kevin D Cassel, Dr. PHPrincipal InvestigatorUniversity of Hawaii Cancer Research Center

Media Library

Quality of Life Supportive Resources Clinical Trial Eligibility Overview. Trial Name: NCT04713007 — N/A

Colon Cancer Research Study Groups: Group A, Group 1

Colon Cancer Clinical Trial 2023: Quality of Life Supportive Resources Highlights & Side Effects. Trial Name: NCT04713007 — N/A

Quality of Life Supportive Resources 2023 Treatment Timeline for Medical Study. Trial Name: NCT04713007 — N/A

~11 spots leftby Feb 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.